|
Group Post |
In theU.S, only 1% of immune-impaired US adults have gotten the recommended 5 COVID vaccine doses |
mike kraft |
|
Group Post |
Long COVID Is Keeping Significant Numbers of People Out of Work--NY Study |
mike kraft |
|
Group Post |
Debate over whether Covid reinfection bring more health risks – or makes you ‘super immune’? |
mike kraft |
|
Group Post |
Two views: U.S. Covid death tolls undercounted, Covid is no longer a national emergency |
mike kraft |
|
Group Post |
China says COVID deaths, severe cases have fallen over 70% since peak |
mike kraft |
|
Group Post |
Bivalent updated COVID-19 boosters struggle to prevent subvariant transmission – reseqarcher says new approaches are necessary |
mike kraft |
|
Group Post |
Opinion: The COVID vaccine success story can be a springboard for future research |
mike kraft |
|
Group Post |
Analysis: Setting the record straight: There is no ‘Covid heart’ |
mike kraft |
|
Group Post |
Updated boosters are cutting the risk of getting sick from Covid-19 by about half--new study |
mike kraft |
|
Group Post |
UK will provide COVID booster dose to higher-risk groups in autumn |
mike kraft |
|
Group Post |
Spain, Japan move toward relaxing mask requirements |
mike kraft |
|
Group Post |
Roche launches new test to detect fast spreading Omicron sub-variant |
mike kraft |
|
Group Post |
Opinion: ... Without clean air, the next infection could permanently disable you |
mike kraft |
|
Group Post |
Will the next worrisome coronavirus variant get detected? |
mike kraft |
|
Group Post |
U.S. FDA panel recomends retiring original Covid vaccine and using newer versions |
mike kraft |
|
Group Post |
FDA experts are still divided over who should get which COVID shots and when |
mike kraft |
|
Group Post |
EU may pay more for Pfizer COVID shots in return for lower volume |
mike kraft |
|
Group Post |
US suffered record number of deaths from cardiovascular disease early in pandemic |
mike kraft |
|
Group Post |
U.S. CDC still looking at whether there is a potential stroke risk from Pfizer bivalent COVID shot |
mike kraft |
|
Group Post |
Analysis: Three years since Covid-19 emerged: What have we learned and what more do we need to understand? |
mike kraft |
|
Group Post |
CDC urges people with weak immune systems to take extra precautions after Evusheld deemed ineffective |
mike kraft |
|
Group Post |
Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases - CDC |
mike kraft |
|
Group Post |
WHO extends public health emergency over Covid but signals end could come soon |
mike kraft |
|
Group Post |
All countries 'dangerously unprepared' for future pandemics, warns IFRC |
mike kraft |
|
Group Post |
Although kids fight off COVID-19 quickly, they don't develop adaptive immunity --study |
mike kraft |
Recent Comments